<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16(6)</volume><submitter>Gentreau M</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Statins are cholesterol-lowering drugs widely prescribed for preventing cardiovascular diseases. They may cause adverse effects on skeletal muscle, but it remains unclear whether they affect muscle function and mass. We aimed to evaluate the association between statin use and muscle function and mass, and whether the pharmacogenomic score (PGS) of statin response modifies these associations.&lt;h4>Methods&lt;/h4>We included 297 977 participants from the UK Biobank. Grip strength was measured using a Jamar J00105 hydraulic hand dynamometer, and the appendicular lean mass (ALM) was estimated using bioelectrical impedance analysis. We performed linear regression to evaluate the cross-sectional and longitudinal associations between statin use and (changes in) grip strength or ALM,</pubmed_abstract><journal>Journal of cachexia, sarcopenia and muscle</journal><pagination>e70132</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12634476</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Statin Use Is Associated With a Decline in Muscle Function and Mass Over Time, Irrespective of Statin Pharmacogenomic Score.</pubmed_title><pmcid>PMC12634476</pmcid><pubmed_authors>Titova OE</pubmed_authors><pubmed_authors>Schioth HB</pubmed_authors><pubmed_authors>Mohammad S</pubmed_authors><pubmed_authors>Rukh G</pubmed_authors><pubmed_authors>Sakr M</pubmed_authors><pubmed_authors>Gentreau M</pubmed_authors><pubmed_authors>Alsehli AM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Statin Use Is Associated With a Decline in Muscle Function and Mass Over Time, Irrespective of Statin Pharmacogenomic Score.</name><description>&lt;h4>Background&lt;/h4>Statins are cholesterol-lowering drugs widely prescribed for preventing cardiovascular diseases. They may cause adverse effects on skeletal muscle, but it remains unclear whether they affect muscle function and mass. We aimed to evaluate the association between statin use and muscle function and mass, and whether the pharmacogenomic score (PGS) of statin response modifies these associations.&lt;h4>Methods&lt;/h4>We included 297 977 participants from the UK Biobank. Grip strength was measured using a Jamar J00105 hydraulic hand dynamometer, and the appendicular lean mass (ALM) was estimated using bioelectrical impedance analysis. We performed linear regression to evaluate the cross-sectional and longitudinal associations between statin use and (changes in) grip strength or ALM,</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-10T05:17:22.644Z</modification><creation>2026-06-10T03:07:19.609Z</creation></dates><accession>S-EPMC12634476</accession><cross_references><pubmed>41267182</pubmed><doi>10.1002/jcsm.70132</doi></cross_references></HashMap>